Dan88 et al,
Much was previously known by those of us that follow nwbo and dcvax, however it still reaffirms our (longs) expectations and when the author states the expectation that dcvax-l will be approved, I take it that the author is conveying the expectation of the medical community dealing with brain malignancies, which I don’t think I’ve seen elsewhere. I know I’m biased as a moderately large long, but it’s still a constructive assessment!
Also, did we ever have confirmation of how many trial patients were alive at the latter part of 2018?
News 
Market Data 
Discover 
